Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 80425-0420

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 80425-0420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr 20mg #30 (Esomeprazole Magnesium Dr 20mg 80425 0420 01)

Esomeprazole Magnesium Dr 20mg #30 (Esomeprazole Magnesium Dr 20mg 80425 0420 01)
Label for Esomeprazole Magnesium delayed-release 20 mg capsules from Advanced Rx of Tennessee, LLC. The label indicates the product is prescription only (Rx Only), includes a lot number and expiration date, instructions for storage at 20°-25°C, and references a comparison to Nexium. It also features barcode information and pharmacy details for Camber Pharmace.*
FDA Label Image

Esomeprazole Magnesium Dr 20mg #60 (Esomeprazole Magnesium Dr 20mg 80425 0420 02)

Esomeprazole Magnesium Dr 20mg #60 (Esomeprazole Magnesium Dr 20mg 80425 0420 02)
Esomeprazole Magnesium 20 mg delayed-release capsules in a blister pack. The label shows packaging and storage information including storage temperature (20°-25°C). It is distributed by Advanced Rx of Tennessee, LLC, Nashville, TN. The NDC is 80425-0420-02. The label also references a comparison to Nexium and includes lot and expiration date fields.*
FDA Label Image

Esomeprazole Magnesium Dr 20mg #90 (Esomeprazole Magnesium Dr 20mg 80425 0420 03)

Esomeprazole Magnesium Dr 20mg #90 (Esomeprazole Magnesium Dr 20mg 80425 0420 03)
Label for Esomeprazole Magnesium DR 20 mg capsules from Advanced Rx of Tennessee, LLC. The label compares this product to Nexium and includes the NDC 80425-0420-03, lot number, and expiration date 9/30/2025. Storage instructions recommend 20°-25°C (68°-77°F). The product is Rx only and the label also mentions pharmacy information and a unique serial number.*
FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)
Chemical structure of esomeprazole magnesium hydrate, showing the molecular components and arrangement including magnesium ion complexed with esomeprazole molecules and water of hydration.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph showing the percentage maintained over a 6-month period for different doses of Esomeprazole Magnesium delayed-release capsules (40 mg, 20 mg, and 10 mg) compared with placebo. The x-axis represents months (0 to 6), and the y-axis shows percent maintained (0 to 100). The graph includes four lines representing each dose and placebo, illustrating the changes in percentage maintained over time.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph depicting the percentage maintenance over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to placebo. The y-axis shows percent maintained, and the x-axis represents months, with data points and trends for each dosage and placebo.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph showing the percentage of patients symptom-free over 28 days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The x-axis represents diary days, and the y-axis shows percent of patients symptom-free, with both 20 mg and 40 mg dosage groups demonstrating higher symptom-free rates compared to placebo.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium Delayed-Release Capsules 40 mg and 20 mg doses against a placebo, illustrating higher symptom-free percentages for both doses compared to placebo over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.